ENANTA PHARMACEUTICALS, INC Stock-Based Compensation
ENANTA PHARMACEUTICALS, INC (ENTA) reported Stock-Based Compensation of $11.24 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.68M, a 11.83% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.75M, a 20.05% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.81M, a 32.76% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.03M, a 47.73% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for fiscal 2025 was $18.57M, a 30.71% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for fiscal 2024 was $26.80M, a 5.04% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for fiscal 2023 was $28.22M, a 4.62% increase from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC share-based payment arrangement, noncash expense for fiscal 2022 was $26.97M, a 28.48% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $7.43M derived: sum of 2 quarters · filed 2026-08-12 | $11.24M 10-Q · filed 2026-08-12 | $15.28M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $7.56M 10-Q · filed 2026-05-13 | $11.59M derived: sum of 3 quarters · filed 2026-05-13 | $15.77M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $3.81M 10-Q · filed 2026-02-11 | $7.84M derived: sum of 2 quarters · filed 2026-02-11 | $12.02M derived: sum of 3 quarters · filed 2026-08-12 | $16.71M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $8.21M derived: sum of 2 quarters · filed 2026-08-12 | $12.90M derived: sum of 3 quarters · filed 2026-08-12 | $18.57M 10-K · filed 2025-11-19 |
| 2025-06-30 | $4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $8.87M derived: sum of 2 quarters · filed 2026-08-12 | $14.53M 10-Q · filed 2026-08-12 | $22.25M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $10.35M 10-Q · filed 2026-05-13 | $18.07M derived: sum of 3 quarters · filed 2026-05-13 | $23.49M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $5.67M 10-Q · filed 2026-02-11 | $13.38M derived: sum of 2 quarters · filed 2026-02-11 | $18.80M derived: sum of 3 quarters · filed 2026-02-11 | $24.36M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $13.13M derived: sum of 2 quarters · filed 2025-11-19 | $18.70M derived: sum of 3 quarters · filed 2025-11-19 | $26.80M 10-K · filed 2025-11-19 |
| 2024-06-30 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | $10.98M derived: sum of 2 quarters · filed 2025-08-13 | $19.08M 10-Q · filed 2025-08-13 | $25.79M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | $5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $13.66M 10-Q · filed 2025-05-14 | $20.38M derived: sum of 3 quarters · filed 2025-11-19 | $27.37M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | $8.10M 10-Q · filed 2025-02-12 | $14.81M derived: sum of 2 quarters · filed 2025-11-19 | $21.81M derived: sum of 3 quarters · filed 2025-11-19 | $29.18M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-09-30 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $13.71M derived: sum of 2 quarters · filed 2025-11-19 | $21.08M derived: sum of 3 quarters · filed 2025-11-19 | $28.22M 10-K · filed 2025-11-19 |
| 2023-06-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | $14.36M derived: sum of 2 quarters · filed 2024-08-07 | $21.50M 10-Q · filed 2024-08-07 | $28.33M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $7.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $14.50M 10-Q · filed 2024-05-08 | $21.34M derived: sum of 3 quarters · filed 2024-11-27 | $28.94M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $7.14M 10-Q · filed 2024-02-08 | $13.97M derived: sum of 2 quarters · filed 2024-11-27 | $21.57M derived: sum of 3 quarters · filed 2024-11-27 | $28.05M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $6.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $14.44M derived: sum of 2 quarters · filed 2024-11-27 | $20.91M derived: sum of 3 quarters · filed 2024-11-27 | $26.97M 10-K · filed 2024-11-27 |
| 2022-06-30 | $7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $14.07M derived: sum of 2 quarters · filed 2023-08-08 | $20.14M 10-Q · filed 2023-08-08 | $25.49M derived: sum of 4 quarters · filed 2023-11-22 |
| 2022-03-31 | $6.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | $12.53M 10-Q · filed 2023-05-09 | $17.89M derived: sum of 3 quarters · filed 2023-11-22 | $23.36M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-12-31 | $6.06M 10-Q · filed 2023-02-08 | $11.41M derived: sum of 2 quarters · filed 2023-11-22 | $16.89M derived: sum of 3 quarters · filed 2023-11-22 | $22.17M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-09-30 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $10.83M derived: sum of 2 quarters · filed 2023-11-22 | $16.11M derived: sum of 3 quarters · filed 2023-11-22 | $20.99M 10-K · filed 2023-11-22 |
| 2021-06-30 | $5.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | $10.76M derived: sum of 2 quarters · filed 2022-08-08 | $15.64M 10-Q · filed 2022-08-08 | $20.38M derived: sum of 4 quarters · filed 2022-11-23 |
| 2021-03-31 | $5.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | $10.16M 10-Q · filed 2022-05-09 | $14.91M derived: sum of 3 quarters · filed 2022-11-23 | $19.66M derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-12-31 | $4.88M 10-Q · filed 2022-02-10 | $9.63M derived: sum of 2 quarters · filed 2022-11-23 | $14.38M derived: sum of 3 quarters · filed 2022-11-23 | $19.36M derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-09-30 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | $9.50M derived: sum of 2 quarters · filed 2022-11-23 | $14.48M derived: sum of 3 quarters · filed 2022-11-23 | $19.57M 10-K · filed 2022-11-23 |
| 2020-06-30 | $4.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | $9.73M derived: sum of 2 quarters · filed 2021-08-09 | $14.83M 10-Q · filed 2021-08-09 | $19.34M derived: sum of 4 quarters · filed 2021-11-24 |
| 2020-03-31 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | $10.08M 10-Q · filed 2021-05-10 | $14.59M derived: sum of 3 quarters · filed 2021-11-24 | $18.75M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-12-31 | $5.10M 10-Q · filed 2021-02-09 | $9.61M derived: sum of 2 quarters · filed 2021-11-24 | $13.77M derived: sum of 3 quarters · filed 2021-11-24 | $18.48M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-09-30 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $8.68M derived: sum of 2 quarters · filed 2021-11-24 | $13.38M derived: sum of 3 quarters · filed 2021-11-24 | $19.23M 10-K · filed 2021-11-24 |
| 2019-06-30 | $4.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | $8.87M derived: sum of 2 quarters · filed 2020-08-10 | $14.71M 10-Q · filed 2020-08-10 | $18.82M derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11 | $10.55M 10-Q · filed 2020-05-11 | $14.66M derived: sum of 3 quarters · filed 2020-11-25 | $18.68M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $5.84M 10-Q · filed 2020-02-10 | $9.95M derived: sum of 2 quarters · filed 2020-11-25 | $13.98M derived: sum of 3 quarters · filed 2020-11-25 | $17.57M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | $4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $8.13M derived: sum of 2 quarters · filed 2020-11-25 | $11.72M derived: sum of 3 quarters · filed 2020-11-25 | $15.85M 10-K · filed 2020-11-25 |
| 2018-06-30 | $4.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | $7.62M derived: sum of 2 quarters · filed 2019-08-09 | $11.73M 10-Q · filed 2019-08-09 | $14.95M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | $3.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $7.71M 10-Q · filed 2019-05-10 | $10.92M derived: sum of 3 quarters · filed 2019-11-27 | $14.02M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-12-31 | $4.12M 10-Q · filed 2019-02-08 | $7.33M derived: sum of 2 quarters · filed 2019-11-27 | $10.43M derived: sum of 3 quarters · filed 2019-11-27 | $13.92M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-09-30 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $6.31M derived: sum of 2 quarters · filed 2019-11-27 | $9.80M derived: sum of 3 quarters · filed 2019-11-27 | $13.07M 10-K · filed 2019-11-27 |
| 2017-06-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | $6.59M derived: sum of 2 quarters · filed 2018-08-09 | $9.86M 10-Q · filed 2018-08-09 | $12.37M derived: sum of 4 quarters · filed 2018-11-29 |
| 2017-03-31 | $3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | $6.76M 10-Q · filed 2018-05-10 | $9.27M derived: sum of 3 quarters · filed 2018-11-29 | $11.74M derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-12-31 | $3.27M 10-Q · filed 2018-02-09 | $5.78M derived: sum of 2 quarters · filed 2018-11-29 | $8.25M derived: sum of 3 quarters · filed 2018-11-29 | $10.63M derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-09-30 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $4.98M derived: sum of 2 quarters · filed 2018-11-29 | $7.36M derived: sum of 3 quarters · filed 2018-11-29 | $9.35M 10-K · filed 2018-11-29 |
| 2016-06-30 | $2.47M 10-Q · filed 2016-08-09 | $4.85M derived: sum of 2 quarters · filed 2016-08-09 | $6.84M 10-Q · filed 2017-08-09 | $8.64M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $2.38M 10-Q · filed 2016-05-10 | $4.37M 10-Q · filed 2017-05-10 | $6.17M derived: sum of 3 quarters · filed 2017-12-11 | $7.75M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $1.99M 10-Q · filed 2017-02-09 | $3.79M derived: sum of 2 quarters · filed 2017-12-11 | $5.37M derived: sum of 3 quarters · filed 2017-12-11 | $6.80M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $3.38M derived: sum of 2 quarters · filed 2017-12-11 | $4.81M derived: sum of 3 quarters · filed 2017-12-11 | $5.84M 10-K · filed 2017-12-11 |
| 2015-06-30 | $1.58M 10-Q · filed 2016-08-09 | $3.01M derived: sum of 2 quarters · filed 2016-08-09 | $4.04M 10-Q · filed 2016-08-09 | $4.84M derived: sum of 4 quarters · filed 2016-12-09 |
| 2015-03-31 | $1.43M 10-Q · filed 2016-05-10 | $2.46M 10-Q · filed 2016-05-10 | $3.25M derived: sum of 3 quarters · filed 2016-12-09 | $4.03M derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-12-31 | $1.03M 10-Q · filed 2016-02-09 | $1.82M derived: sum of 2 quarters · filed 2016-12-09 | $2.60M derived: sum of 3 quarters · filed 2016-12-09 | $3.35M derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-09-30 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | $1.57M derived: sum of 2 quarters · filed 2016-12-09 | $2.32M derived: sum of 3 quarters · filed 2016-12-09 | $2.68M 10-K · filed 2016-12-09 |
| 2014-06-30 | $776.00K 10-Q · filed 2015-08-10 | $1.53M derived: sum of 2 quarters · filed 2015-08-10 | $1.89M 10-Q · filed 2015-08-10 | $2.17M derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $752.00K 10-Q · filed 2015-05-08 | $1.11M 10-Q · filed 2015-05-08 | $1.40M derived: sum of 3 quarters · filed 2015-12-11 | $1.64M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $359.00K 10-Q · filed 2015-02-06 | $645.00K derived: sum of 2 quarters · filed 2015-12-11 | $884.00K derived: sum of 3 quarters · filed 2015-12-11 | $1.14M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $525.00K derived: sum of 2 quarters · filed 2015-12-11 | $782.00K derived: sum of 3 quarters · filed 2015-12-11 | $1.06M 10-K · filed 2015-12-11 |
| 2013-06-30 | $239.00K 10-Q · filed 2014-08-12 | $496.00K derived: sum of 2 quarters · filed 2014-08-12 | $777.00K 10-Q · filed 2014-08-12 | $1.02M derived: sum of 4 quarters · filed 2014-12-11 |
| 2013-03-31 | $257.00K 10-Q · filed 2014-05-12 | $538.00K 10-Q · filed 2014-05-12 | $781.00K derived: sum of 3 quarters · filed 2014-12-11 | $876.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-12-31 | $281.00K 10-Q · filed 2014-02-13 | $524.00K derived: sum of 2 quarters · filed 2014-12-11 | $619.00K derived: sum of 3 quarters · filed 2014-12-11 | $650.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-09-30 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $338.00K derived: sum of 2 quarters · filed 2014-12-11 | $369.00K derived: sum of 3 quarters · filed 2014-12-11 | $424.00K 10-K · filed 2014-12-11 |
| 2012-06-30 | $95.00K 10-Q · filed 2013-08-12 | $126.00K derived: sum of 2 quarters · filed 2013-08-12 | $181.00K 10-Q · filed 2013-08-12 | |
| 2012-03-31 | $31.00K 10-Q · filed 2013-05-15 | $86.00K 10-Q · filed 2013-05-15 | ||
| 2011-09-30 | $225.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |